Association between the C3435T polymorphism of human multidrug resistance 1 gene and refractory epilepsy

( views:225, downloads:0 )
Author:
DI Qing(Department of Neurology, Brain Hospital Affiliated to Nanjing Medical University, Nanjing 210029, China)
WANG Ling-ling(Department of Neurology, Brain Hospital Affiliated to Nanjing Medical University, Nanjing 210029, China)
XU Li-gang(Department of Neurology, Brain Hospital Affiliated to Nanjing Medical University, Nanjing 210029, China)
YU Nian(Department of Neurology, Brain Hospital Affiliated to Nanjing Medical University, Nanjing 210029, China)
JIANG Ying(Department of Neurology, Brain Hospital Affiliated to Nanjing Medical University, Nanjing 210029, China)
JIANG Wei-wei(Department of Neurology, Brain Hospital Affiliated to Nanjing Medical University, Nanjing 210029, China)
SUN Feng(Department of Neurology, Brain Hospital Affiliated to Nanjing Medical University, Nanjing 210029, China)
GE Jian-qing(Department of Neurology, Brain Hospital Affiliated to Nanjing Medical University, Nanjing 210029, China)
ZHANG Ying-dong(Department of Neurology, Brain Hospital Affiliated to Nanjing Medical University, Nanjing 210029, China)
Journal Title:
CHINESE JOURNAL OF NEUROMEDICINE
Issue:
Volume 10, Issue 02, 2011
DOI:
10.3760/cma.j.issn.1671-8925.2011.02.004
Key Word:
Epilepsy;Drug-resistance;P-glycoprotein;Multidrug resistance gene;Genetic polymorphism

Abstract: Objective To clarify the relation between the C3435T polymorphism of multidrug resistance 1 (MDR1) gene and human refractory epilepsy (RE) in ethnic Han Chinese. Methods We collected 170 patients with epilepsy, whose diagnoses were correct and treatments were reasonable. RE was defined as having uncontrolled seizures that occurred with an average frequency of at least once a month for a period of at least 2 years; during the 2-years period, at least 2 different antiepileptic drugs (AEDs) were used daily, either singly or in combination. According to the definition, 91 patients were classified into RE group and the other 79 patients into non-RE group. A 5-mL venous blood sample was taken from the patients for DNA extraction and genotyping. Genotype of C3435T polymorphism in MDR1 gene was determined by polymerase chain reaction followed by restriction fragment length polymorphism (PCR-RFLP). Results The distribution of CC, CT, TT genotypes was 48.4%, 40.7%,11.0% in RE group, and 40.5%, 38.0%, 21.5% in non-RE group, respectively; no significant differences of C3435T genotype were noted between the 2 groups (x2=3.615, P=0.164). The C and T allele frequencies were 68.7%, 31.3% in RE group, and 59.5%, 40.5% in non-RE group, respectively; no significant differences were found between 2 groups (x2=3.112, P=0.080). Patients were divided into primary epilepsy group and cryptogenic or symptomatic epilepsy group according to the etiology;analyses of the genotype and allele of C3435T in the sub-groups (RE and non-RE subgroups) of this 2 groups were similarly unremarkable. Conclusion No association between the C3435T polymorphism in MDR1 gene and RE in ethnic Han Chinese is noted.

  • [1]刘仕勇,安宁,杨辉.药物难治性癫痫外科治疗展望[J].中华神经医学杂志,2009,8(3):316-318.
  • [2]Lazarowski A,Czomyj L,Lubienieki F,et al.ABC transporters during epilepsy and mechanisms underlying multidrug resistance in refractory epilepsy[J].Epilepsia,2007,48(Suppl 5):140-149.
  • [3]Siddiqui A,Kerb R,Weale ME,et al.Association of multidrug resistance in epilepsy with a polymorphism in the drug-transporter gene ABCB[J].N Engl J Med,2003,348 (15):1442-1448.
  • [4]Sills GJ,Mohanraj R,Butler E,et al.Lack of association between the C3435T polymorphism in the human multidrug resistance (MDR1) gene and response to antiepileptic drug treatment[J].Epilepsia,2005,46(5):643-647.
  • [5]Zimprich F,Sunder-Plassmann R,Stogmann E,et al.Association of an ABCB1 gene haplotype with pharmacoresistance in temporal lobe epilepsy[J].Neurology,2004,63(6):1087-1089.
  • [6]Hung CC,Tai JJ,Lin CJ,et al.Complex haplotypic effects of the ABCB1 gene on epilepsy treatment response[J].Pharmacogenomies,2005,6(4):411-417.
  • [7]Kim YO,Kim MK,Woo YJ,et al.Single nucleotide polymorphisms in the multidrug resistance 1 gene in Korean epileptics[J].Seizure,2006,15(1):67-72.
  • [8]Lakhan R,Misra UK,Kalita J,et al.No association of ABCB1 polymorphisms with drug-refractory epilepsy in a north Indian population[J].Epilepsy Behav,2009,14(1):78-82.
  • [9]Kwan P,Larry Baum L,Wong V,et al.Association between ABCB1 C3435T polymorphism and drug-resistant epilepsy in Han Chinese[J].Epilepsy Behav,2007,11(1):112-117.
  • [10]郑兴珍,武士京,夏敏,等.难治性癫痫的耐药性与多药耐药基因MDR1 C3435T多态性的相关研究[J].中风与神经疾病杂志,2009,26(1):44-46.
  • [11]陆骏超,任惠民,朱国行,等.多药耐药基因1C3435 T多态性在癫痫患者中的分布[J].中华神经科杂志,2007,40(9):584-587.
  • [12]陈黎,刘昌勤,胡雁,等.儿童癫痫对药物反应性与多药耐药基因MDR1 C3435T多态性的相关性研究[J].中国当代儿科杂志,2007,9(1):11-14.
  • [13]王水有,夏峰,夏哲智,等.儿童难治性癫痫与MDR1基因C3435T多态性的相关性[J].浙江医学,2008,30(12):1307-1309,1312.
  • [14]Ameyaw MM,Regateiro F,Li T,et al.MDR1 pharmacogenetics:frequency of the C3435T mutation in exon 26 is significantly influenced by ethnicity[J].Pharmacogenetics,2001,11(3):217-221.
  • [15]Wang D,Sadee W.Searching for polymorphisms that affect gene expression and mRNA processing:example ABCB1 (MDR1)[J].AAPS J,2006,8(3):E515-520.
  • [16]Hughes JR.One of the hottest topics in epileptology:ABC proteins.Their inhibition may be the future for patients with intractable seizures[J].Neurol Res,2008,30(9):920-925.
  • [17]Bournissen FG,Moretti ME,Juurlink DN,et al.Polymorphism of the MDR1/ABCB1 C3435T drug-transporter and resistance to anticonvulsant drugs:a meta-analysis[J].Epilepsia,2009,50(4):898-903.
  • [18]岑宇翔,陆志诚,汪华侨,等.汉族人MDR1 C3435T基因的多态性[J]解剖学研究,2004,26(1):11-13.
WanfangData CO.,Ltd All Rights Reserved
About WanfangData | Contact US
Healthcare Department, Fuxing Road NO.15, Haidian District Beijing, 100038 P.R.China
Tel:+86-010-58882616 Fax:+86-010-58882615 Email:yiyao@wanfangdata.com.cn